CIK: 1201040 - Address: C/o Enzon Pharmaceuticals, Inc., 685 Route 202/206, Bridgewater, NJ 08807
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret114493443396933
P%wins1007510010010010096

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/13/08 17:28
11/13/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBuchalter Jeffrey HNJDOCB,CEO,PP1643.2825012453D-62-69-66-67-56-41-38-306157511398210
8/21/07 12:22
8/20/07
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBuchalter Jeffrey HNJDOCB,CEO,PP377.46753203D8-1-8-818141055521817
3/7/06 18:17
3/7/06
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBuchalter Jeffrey HNJDOCB,CEO,PP696.8621011982-12381916
6/10/05 17:17
6/10/05
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagBuchalter Jeffrey HNJDOCEOP585.753101388D-58-54-58-45-24-11-3121831292931

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact